Ranbaxy now faces heat at home

Health ministry seeks report from drug controller in a month


Pankaj Kumar | May 25, 2013

Ranbaxy, punished by a US court this month for quality violations in drug manufacturing, now faces heat at home. The health ministry has asked the drug controller general of India to examine the documents, dossiers and the approval given to the largest pharma firm of the country.

"Regulators will evaluate all the documents related to Ranbaxy to see weather the quality control mechanism has been taken care of fully as per norms in seeking approvals by Ranbaxy," a senior health ministry officer told Governance Now.

A report is expected to be prepared in a month. However, the question remains why Indian authorities took no action when there was uproar in parliament over this issue after US FDA leveled charges against Ranbaxy in 2008.

The ministry had probed the matter in late 2008 but decided not to ban the drugs manufactured at two of the Ranbaxy facilities at Dewas and Paonta Sahib. In fact, the drug controller had inspected the two facilities and found nothing objectionable.



Other News

Voter turnout: Drop from 2019 reduces further

As the voting percentages dropped drastically in the first couple of phases of the ongoing general elections, observers and analysts spoke of ‘voter apathy’ blamed it on a lack of “wave” this time – apart from the heatwave, that is. The latest figures after the fourth phase, h

GAIL reports annual revenue of Rs.1,30,638 crore

GAIL (INDIA) Limited has reported 75% increase in Profit before Tax (PBT) of Rs.11,555 crore in FY24,  as against Rs 6,584 Cr in FY23. Profit after Tax (PAT) in FY24 stands at Rs. 8,836 Cr as against Rs.5,302 Cr in FY23, a 67 % increase. However, revenue from operations registered a fa

Women move forward, one step at a time

“Women’s rights are not a privilege but a fundamental aspect of human rights.” —Savitribai Phule In India, where almost two-thirds of the population resides in rural areas, women’s empowerment initiatives are extremely critical for intensifying l

Why you should vote

What are the direct tangible benefits that you want from the government coming in power? The manifestos of various parties set a host of agendas which many times falls back in materialising the intended gains. Governance failures, policy lapses, implementation gaps, leadership crisis and cultural blockages

How the role of Ayurveda evolved pre- and post-independence

Ayurveda, Nation and Society: United Provinces, c. 1890–1950 By Saurav Kumar Rai Orient BlackSwan, 292 pages, Rs 1,400  

General Elections: Phase 4 voting on in 96 seats

As many as 17.7 crore electors are eligible to vote in the fourth phase of general elections taking place on Monday in 10 states/UTs. 175 Legislative Assembly seats of Andhra Pradesh and 28 Legislative Assembly seats of Odisha are also going to polls in this phase. Polling time in select as

Visionary Talk: Amitabh Gupta, Pune Police Commissioner with Kailashnath Adhikari, MD, Governance Now


Current Issue


Facebook Twitter Google Plus Linkedin Subscribe Newsletter